Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Loma Linda, Quark Pharmaceuticals, and More

Premium

Title: Apoptotic Cell-mediated Transfection of Mammalian Cells with Interfering RNA

Patent Number: 8,637,476

Filed: Oct. 4, 2010

Lead Inventor: Fengchun Li, Loma Linda University


Title: Antigenic Compositions and Use of Same in the Targeted Delivery of Nucleic Acids

Patent Number: 8,637,477

Filed: Aug. 29, 2008

Lead Inventor: Rajan George, Akshaya Bio


Title: Methods for Treating Chronic Kidney Disease

Patent Number: 8,637,482

Filed: June 7, 2010

Lead Inventor: Elena Feinstein, Quark Pharmaceuticals

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.